Matches in Wikidata for { <http://www.wikidata.org/entity/Q91142683> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91142683 description "article scientifique publié en 2018" @default.
- Q91142683 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91142683 description "scientific article published on 25 August 2018" @default.
- Q91142683 description "wetenschappelijk artikel" @default.
- Q91142683 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91142683 name "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 name "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 type Item @default.
- Q91142683 label "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 label "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 prefLabel "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 prefLabel "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 P1433 Q91142683-CD123F6B-E00C-4841-99D0-F5003357E794 @default.
- Q91142683 P1476 Q91142683-2EF898C5-7B5B-4B98-80A9-858AD5743A4F @default.
- Q91142683 P2093 Q91142683-02392E46-9539-442F-950A-E793DE143B21 @default.
- Q91142683 P2093 Q91142683-03C4BA68-F4E0-4140-A92A-6B4A9CB83BF5 @default.
- Q91142683 P2093 Q91142683-4319DA4A-BFF1-4012-A666-BEE261656F09 @default.
- Q91142683 P2093 Q91142683-71D87D7C-EB38-4948-A4A0-28C31F55F0D3 @default.
- Q91142683 P2093 Q91142683-82388A5A-EABE-4D76-B422-51F1F8BE8F93 @default.
- Q91142683 P2093 Q91142683-8BDF3073-AE8A-4D9C-82F3-AAC7E03A24A6 @default.
- Q91142683 P2093 Q91142683-B368E99D-B107-46B7-AC7D-59FCC8F44A70 @default.
- Q91142683 P2093 Q91142683-B886EB0A-ED40-4952-AC6A-730840F99101 @default.
- Q91142683 P2093 Q91142683-D6C36BC3-D464-4C61-89AD-8AC3C5713063 @default.
- Q91142683 P304 Q91142683-F95A029A-58D1-43CF-A6E9-DEFCA7F3102C @default.
- Q91142683 P31 Q91142683-33C79D91-07F9-4769-8F21-F89D44321015 @default.
- Q91142683 P356 Q91142683-4051FC48-F402-4E13-9FA2-DC5989B2C7A3 @default.
- Q91142683 P433 Q91142683-C7A324F7-0D03-4EA2-AB74-1A0D6DA86890 @default.
- Q91142683 P478 Q91142683-E7BB8056-9364-4A36-8E2A-766D2AEDD681 @default.
- Q91142683 P577 Q91142683-3C6587A4-9BCF-4FD6-BAF8-4F027C181718 @default.
- Q91142683 P698 Q91142683-F9DB0E9F-2A74-4305-AE4D-EDF38C2F67C4 @default.
- Q91142683 P921 Q91142683-AC17DBD0-9344-4FE0-818E-D858D9EA1340 @default.
- Q91142683 P921 Q91142683-E1F0B767-2DF7-4D45-A7B4-C3AD3E8CD046 @default.
- Q91142683 P356 S10637-018-0659-9 @default.
- Q91142683 P698 30145624 @default.
- Q91142683 P1433 Q2312231 @default.
- Q91142683 P1476 "Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma" @default.
- Q91142683 P2093 "Anne-Sophie Gauthier" @default.
- Q91142683 P2093 "Charlée Nardin" @default.
- Q91142683 P2093 "Christophe Borg" @default.
- Q91142683 P2093 "Eve Puzenat" @default.
- Q91142683 P2093 "Franck Schillo" @default.
- Q91142683 P2093 "François Aubin" @default.
- Q91142683 P2093 "Françoise Cattin" @default.
- Q91142683 P2093 "Marie-Astride Beaudoin" @default.
- Q91142683 P2093 "Sophie Borot" @default.
- Q91142683 P304 "375-377" @default.
- Q91142683 P31 Q13442814 @default.
- Q91142683 P356 "10.1007/S10637-018-0659-9" @default.
- Q91142683 P433 "2" @default.
- Q91142683 P478 "37" @default.
- Q91142683 P577 "2018-08-25T00:00:00Z" @default.
- Q91142683 P698 "30145624" @default.
- Q91142683 P921 Q13896859 @default.
- Q91142683 P921 Q18975855 @default.